Unfortunately, we have seen increasing examples in recent years of pharmaceutical companies exploiting the current structure of our nation's regulatory and patent system to block competition and keep drug prices high through practices like product hopping.
Highlighting the manipulation of regulations by pharmaceutical companies to maintain high prices.
Share
More from Debbie Dingell
Let's stop wasting time on illegitimate messaging CRAs and work together to support innovation, build out the infrastructure, ensure access to affordable American-made vehicles, whether gas-powered, hybrid, or electric. Let's work together…
I strongly urge my colleagues to protect American citizens and support the ROUTERS Act. Mr. Speaker, I yield back the balance of my time.
Other voices in this conversation
